An Article"MedMira, Inc. (CVE:MIR) (PINK:MMIRF) stock price gapped up after the company's rapid HIV test product got approved by a regulator.
Stock price gained 33.3% under a heavy trading volume of 3.7 million. That was more than 20 times heavier than normal. The trading was quite boring though - share price stood still for most of the session, holding the newly gained pricing.
The share price didn't leave its trading channel which has been mostly intact since 2010. Although the new approval means additional income is at hand, not even speculative numbers were given in the press release, which leaves space only for speculations, not facts-based trading. In this case, the lack of engagement from traders has mostly eliminated the possibility of speculation altogether.
The stock gained after the company stated their rapid HIV test was approved by the United States Agency for International Development. Reveal HIV is MedMira's most advanced product of the kind. This approval means the product is eligible for procurement with funds provided by the USAID.
With this approval the company will be able to offer three formats of the test to select from. Their main target is the large scale orders from projects funded by USAID and PEPFAR which engage in global HIV prevention and control."
The money is going to flood in soon.
From: https://ca.hotstocked.com/article/34192/medmira-inc-cve-mir-pink-mmirf.html